Fool.com
The World's Greatest Investing Community
Results 41 - 50 of 1081 : Previous 1 2 3 4 5 6 7 8 9 Next
A Little Distracted, Are You, Merck?
The FDA rejects its latest application.
It still has a big bet ahead of it, though.
A Stupid Idea That Deserves to Die
If you think markets are efficient, I've got a bridge to sell you.
Finally Convinced? Benlysta Works!
Human Genome Sciences succeeds where others have failed.
Winners and Losers of the House Health-Care Reform Bill
There's something for everyone to hate.
Shrugging Off the Side Effects
Sanofi is looking good, but still faces the loss of Lovenox.
Of One-Time Gains and Pipelines
AstraZeneca had some of both during the third quarter.
Should You Dump These Dividend Stocks?
Yields are looking thinner.
Thursday's Biggest Stock Stars
Yesterday's market is today's moneymaking road map.
World's Scariest Stocks: Pfizer
It may be a known unknown, but it still gives me the willies.
Legal Information © 1995 - 2009 The Motley Fool. All rights reserved.
Market Data provided by 
Terms & Conditions
RSS Headlines
Fool UK